Draco Healthcare President Dr. Linda Zhao to Present a Session on FDA Goes Global: Domestic Mission – Global Presence at the 45th DIA Annual Conference, San Diego
Fremont, CA, June 13, 2009 --(PR.com)-- Draco Healthcare Consulting LLC is pleased to announce that Draco CEO Dr. Linda Zhao will present a session at the Drug Information Association’s (DIA’s) 45th Annual Meeting (June 21-25, 2008; San Diego, CA).
The DIA Annual Meeting is the biopharmaceutical industry's largest, longest running, best-value, global, multidisciplinary event. This year's program offers learning opportunities for everyone and features the biggest names from industry, regulatory, and academia.
Dr. Linda Zhao will deliver a presentation on Regulatory Changes in China. A successful approval in China demands thorough understanding of the Chinese drug regulatory system and efficient utilization of China’s capacity for clinical trials. Recent changes in China’s regulatory sector include a new leader to its drug regulatory authority, the State Food and Drug Administration (SFDA), the new Drug Registration Procedure effective on October 1, 2007, a new Drug Recall Procedure effective on December 10, 2007 and the new GMP Procedure effective on January 1, 2008. With the newly announced healthcare reform plan, the Chinese healthcare market is positioned for continued explosive growth as more and more Chinese residents are having healthcare insurance coverage and the access to care is getting easier.
About Draco
Draco Healthcare Consulting LLC is a China-focused company, providing healthcare consulting services exclusively about the China’s emerging and rapidly expanding pharmaceutical industry. Draco publishes syndicated Chinese pharmaceutical reports as well as provides healthcare consulting services. Draco’s core reports include the Chinese Drug Hospital Market Reports, the Chinese Cancer Epidemiology Data and the Chinese Epidemiology Reports (non-cancer) for other key diseases in China. For more information, visit www.dracohealthcare.com or call 510-585-9326
About the Drug Information Association (DIA)
DIA serves more than 30,000 biopharmaceutical professionals from industry, academia, and regulatory agencies worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.
###
The DIA Annual Meeting is the biopharmaceutical industry's largest, longest running, best-value, global, multidisciplinary event. This year's program offers learning opportunities for everyone and features the biggest names from industry, regulatory, and academia.
Dr. Linda Zhao will deliver a presentation on Regulatory Changes in China. A successful approval in China demands thorough understanding of the Chinese drug regulatory system and efficient utilization of China’s capacity for clinical trials. Recent changes in China’s regulatory sector include a new leader to its drug regulatory authority, the State Food and Drug Administration (SFDA), the new Drug Registration Procedure effective on October 1, 2007, a new Drug Recall Procedure effective on December 10, 2007 and the new GMP Procedure effective on January 1, 2008. With the newly announced healthcare reform plan, the Chinese healthcare market is positioned for continued explosive growth as more and more Chinese residents are having healthcare insurance coverage and the access to care is getting easier.
About Draco
Draco Healthcare Consulting LLC is a China-focused company, providing healthcare consulting services exclusively about the China’s emerging and rapidly expanding pharmaceutical industry. Draco publishes syndicated Chinese pharmaceutical reports as well as provides healthcare consulting services. Draco’s core reports include the Chinese Drug Hospital Market Reports, the Chinese Cancer Epidemiology Data and the Chinese Epidemiology Reports (non-cancer) for other key diseases in China. For more information, visit www.dracohealthcare.com or call 510-585-9326
About the Drug Information Association (DIA)
DIA serves more than 30,000 biopharmaceutical professionals from industry, academia, and regulatory agencies worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.
###
Contact
Draco Healthcare Consulting LLC
Linda Zhao
510-585-9326
www.dracohealthcare.com
Linda Zhao
510-585-9326
www.dracohealthcare.com
Contact
Categories